Hematologic Malignancies Grand Rounds

Speakers:                    Barry Paul, MD

Topic:                          “Targeting the Target: The Role of Cereblon Expression in Response to Immunomodulatory Agents in Multiple Myeloma”

Date:                           Friday, November 16, 2018

NEW Time:                 9:10am- 10:00am

Location:                     M224 Markee Classroom, Second Floor, Green Zone, Duke South Clinic's Davison Building

Summary of Faculty Disclosure/Planning Committee
The following speakers and/or planning committee members have indicated he has relationship(s) with industry to disclose relative to the content of this CE activity: Dr. Barry Paul has indicated he is a Stockholder with Bristol-Myers Squibb and a Speaker with Celegene.

Joint Accreditation Statement

In support of improving patient care, Duke University Health System Department of Clinical Education and Professional Development is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the health care team.
 

Education Credits

Category 1*: Duke University Health System Department of Clinical Education and Professional Development designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)^TM. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Disclosures

It is the policy of the Duke University Health System Clinical Education and Professional Development to require the disclosure of anyone who is in a position to control the content of an educational activity. All relevant financial relationships with any commercial interests and/or manufacturers must be disclosed to participants at the beginning of each activity.

You must text the six letter code provided by the speaker to (919)213-8033 to receive credit for attending this conference.